Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03137121 · ClinicalTrials.gov registry record · Phase 2

Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients

A Phase 2 study of Advanced Cancer, sponsored by University of Alabama at Birmingham.

Completed
Registry status
Phase 2
Development phase
30
Enrollment target
5
Study locations

NCT03137121 is a Phase 2 study of Advanced Cancer that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 30 participants, below the 246-participant average among 122 other Advanced Cancer trials with a reported enrollment target (88% lower). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03137121, a Phase 2 study of Advanced Cancer, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
Phase 2
Development phase
30 participants
Enrollment target
5
Study locations

Study Summary

The purpose of this study is to evaluate the use of olanzapine for the treatment of cancer patients with chronic nausea and/or vomiting unrelated to chemotherapy or radiation in a randomized placebo-controlled pilot trial.

Conditions Studied

Advanced Cancer

Interventions

  • OTHER Placebo
  • DRUG Olanzapine

Study Locations (5)

Alabama

  • University of Alabama at Birmingham - Birmingham

Indiana

  • Indiana University - Indianapolis

Minnesota

  • Mayo Clinic - Rochester

Missouri

  • Washington University School of Medicine - St Louis

Wisconsin

  • Hospital Sisters Health System (HSHS) St. Vincent Hospital - Green Bay

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2017-07-12
Est. Completion 2020-09-15
Phase Phase 2

Sponsor

University of Alabama at Birmingham

1,160 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03137121

The ClinicalTrials.gov registry entry for NCT03137121 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 246-participant average among 122 other Advanced Cancer trials with a reported enrollment target (88% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Advanced Cancer appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT03137121 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Alabama, Indiana, Minnesota.

Frequently Asked Questions

What is clinical trial NCT03137121 about?

NCT03137121 is a clinical study titled "Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients". The purpose of this study is to evaluate the use of olanzapine for the treatment of cancer patients with chronic nausea and/or vomiting unrelated to chemotherapy or radiation in a randomized placebo-controlled pilot trial.

What is the current status of trial NCT03137121?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2017-07-12. Estimated completion is 2020-09-15.

What conditions does trial NCT03137121 study?

This clinical trial studies the following conditions: Advanced Cancer.

What interventions are being tested in trial NCT03137121?

The interventions under investigation include: Placebo (OTHER), Olanzapine (DRUG).

Who is sponsoring clinical trial NCT03137121?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03137121 being conducted?

This trial has 5 study locations across Alabama, Indiana, Minnesota, Missouri, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Advanced Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Advanced Cancer

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.